One Day MD | Evidence-Based Wellness

A comprehensive analysis merging clinical trials on high-dose fermented soy enzyme therapy, statin head-to-head comparisons, and plaque regression mechanisms. Atherosclerosis remains the leading cause of cardiovascular events worldwide. While statins focus primarily on lowering low-density lipoprotein (LDL) cholesterol, groundbreaking clinical research reveals that nattokinase —a fibrinolytic enzyme derived from traditional Japanese nattō —acts directly on the structural matrix of established arterial plaque. Credit: Oasis Medical Institute 1. The Head-to-Head Clinical Trial (Ren et al., 2017) In a 26-week randomized controlled study, 82 patients with carotid atherosclerosis received either Nattokinase (6,000 FU/day) or Simvastatin (20 mg/day). Key outcomes included: Carotid Plaque Reduction: Nattokinase achieved a 36.6% reduction in plaque area vs. 11.5% in the statin group. HDL Elevation: Nattokinase significantly increased benefici...

Nattokinase (NK) is an enzyme derived from a traditional Japanese food called natto. Nattokinase is good for atherosclerosis (add magnesium), vascular health, stroke prevention, and clot prevention. Interestingly, Nattokinasi also contains high amounts of vitamin K2. K2 helps to pull the calcium where it shouldn’t be and into the bone where it should be. Low amounts of K2 cause calcium to build up in the arteries. Nattokinase for Blood Clots Nattokinase dissolves blood clots by directly hydrolyzing fibrin and plasmin substrate. It converts endogenous prourokinase to urokinase (uPA). It also degrades plasminogen activator inhibitor (PAI-1) and increases the level of tissue plasminogen activator (t-PA). ( Source ) Furthermore,  a study  has also suggests that daily NK supplementation is an effective way to manage the progression of atherosclerosis and potentially may be a better alternative to statins which are commonly used to reduce atherosclerosis and further to prevent ...